Beckman Coulter Life Sciences completes first phase of Colorado Research and Development Hub with grand opening of $10 million Loveland offices

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, further strengthens its commitment to the greater Loveland, Colorado community with the completion of the first phase of its new research and development hub.

Beckman Coulter Life Sciences completes first phase of Colorado Research and Development Hub with grand opening of $10 million Loveland officesImage Credit: Beckman Coulter Life Sciences

The grand opening of the new $10 million office complex will house its growing workforce in the Axis 25 Development at 4510 Byrd Drive near the Northern Colorado Regional Airport. As part of the expansion, the company also projects the creation of 85 new high-paying Loveland  jobs in the coming years in fields including science research, engineering, and project management. The company currently employs more than 140 full-time associates in Loveland.

The relentless pursuit of innovation is what drives our business and our associates each and every day.

We continue to be impressed by the talent community that exists in greater Loveland, which has fueled our growth in Colorado since we came here in 2018 with nearly three-dozen associates. Our instruments are on the frontlines of major global research facilities, providing them with valuable automation solutions to accelerate answers for that next big breakthrough moment. We’re thrilled to be expanding in Loveland, where our growing team will play a key role in that evolution.”

Suzanne Foster, President, Beckman Coulter Life Sciences.

The new state-of-the-art complex includes 56,000 square feet of office space featuring collaboration zones, breakout rooms, technology centers, gathering spaces, and a gym for associates.

The facility also includes a new innovative Customer Engagement Center which allows customers an inside look at the solutions available from Beckman Coulter Life Sciences, along with how they are created and can be tailored to meet individual and specialized laboratory needs.

The company also formally announces the initiation of its second phase of expansion in Loveland, with a 37,000-square-foot manufacturing operation to be attached to the office site. Ground is set to be broken by the second quarter of 2023, with an anticipated completion date in early 2024.

I am excited to congratulate Beckman Coulter Life Sciences on their official opening today in Loveland, creating 85 good-paying jobs in Northern Colorado. As Colorado continues to position itself as a leader in advanced industries like bioscience, I am thrilled to see more companies choosing to move and expand in our state.”

Jared Polis, Colorado Governor.

Beckman Coulter Life Sciences is also giving back to the greater Loveland community with a donation to Restoring Colorado’s Forests, which will ensure the planting of 140 trees – one for each current associate – to replace those lost due to the recent devastating wildfires and other environmental damage.

Beckman Coulter Life Sciences was assisted by CBRE, Etkin Johnson Real Estate Partners, and the Colorado Office of Economic Development and International Trade.

Job postings will continue to be updated at www.beckman.com/careers.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Beckman Coulter Life Sciences. (2023, January 20). Beckman Coulter Life Sciences completes first phase of Colorado Research and Development Hub with grand opening of $10 million Loveland offices. News-Medical. Retrieved on April 25, 2024 from https://www.news-medical.net/news/20230120/Beckman-Coulter-Life-Sciences-completes-first-phase-of-Colorado-Research-and-Development-Hub-with-grand-opening-of-2410-million-Loveland-offices.aspx.

  • MLA

    Beckman Coulter Life Sciences. "Beckman Coulter Life Sciences completes first phase of Colorado Research and Development Hub with grand opening of $10 million Loveland offices". News-Medical. 25 April 2024. <https://www.news-medical.net/news/20230120/Beckman-Coulter-Life-Sciences-completes-first-phase-of-Colorado-Research-and-Development-Hub-with-grand-opening-of-2410-million-Loveland-offices.aspx>.

  • Chicago

    Beckman Coulter Life Sciences. "Beckman Coulter Life Sciences completes first phase of Colorado Research and Development Hub with grand opening of $10 million Loveland offices". News-Medical. https://www.news-medical.net/news/20230120/Beckman-Coulter-Life-Sciences-completes-first-phase-of-Colorado-Research-and-Development-Hub-with-grand-opening-of-2410-million-Loveland-offices.aspx. (accessed April 25, 2024).

  • Harvard

    Beckman Coulter Life Sciences. 2023. Beckman Coulter Life Sciences completes first phase of Colorado Research and Development Hub with grand opening of $10 million Loveland offices. News-Medical, viewed 25 April 2024, https://www.news-medical.net/news/20230120/Beckman-Coulter-Life-Sciences-completes-first-phase-of-Colorado-Research-and-Development-Hub-with-grand-opening-of-2410-million-Loveland-offices.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System